Skip to main content
Year archive

KOREAN DRUG CO., LTD. — 2023 filings

All 26 regulatory filings released by KOREAN DRUG CO., LTD. (014570) in 2023, sourced directly from the official regulator.

26 Filings
2023 Period
2023 filings (26)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2023-12-15 Korean
자기주식처분결과보고서
Transaction in Own Shares
2023-12-06 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2023-12-04 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
자기주식처분결과보고서
Transaction in Own Shares
2023-11-01 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2023-10-30 Korean
자기주식처분결과보고서
Transaction in Own Shares
2023-10-18 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2023-10-16 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
자기주식처분결과보고서
Transaction in Own Shares
2023-07-06 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2023-07-03 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
벌금등의부과
Legal Proceedings Report
2023-04-14 Korean
자기주식처분결과보고서
Transaction in Own Shares
2023-04-06 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2023-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-17 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-17 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-09 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-09 Korean
주요사항보고서(영업정지)
Legal Proceedings Report
2023-02-22 Korean
주주총회소집공고
AGM Information
2023-02-22 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-02-22 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2023-02-21 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-21 Korean
주주총회소집결의
AGM Information
2023-02-21 Korean
투자판단관련주요경영사항('옥시라세탐'제제의 의약품 재평가 결과 효능·효과에 대한 유효성을 입증하지 못함에 따른 사용중지 권고 의약품 정보 서한 배포)
Legal Proceedings Report
2023-01-16 Korean